Thomas Pleli

1.3k total citations
23 papers, 1.1k citations indexed

About

Thomas Pleli is a scholar working on Molecular Biology, Cancer Research and Hepatology. According to data from OpenAlex, Thomas Pleli has authored 23 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Cancer Research and 5 papers in Hepatology. Recurrent topics in Thomas Pleli's work include MicroRNA in disease regulation (6 papers), Extracellular vesicles in disease (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Thomas Pleli is often cited by papers focused on MicroRNA in disease regulation (6 papers), Extracellular vesicles in disease (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Thomas Pleli collaborates with scholars based in Germany, Egypt and Singapore. Thomas Pleli's co-authors include Albrecht Piiper, Stefan Zeuzem, Oliver Waidmann, Bernd Kronenberger, Verena Köberle, Christian Schmithals, Jörg Trojan, Jan Peveling‐Oberhag, Fabian Finkelmeier and Harald Farnik and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cancer Research.

In The Last Decade

Thomas Pleli

23 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Pleli Germany	17	599	448	233	186	167	23	1.1k
Tianqiang Song China	18	749 1.3×	570 1.3×	145 0.6×	89 0.5×	88 0.5×	31	1.1k
Shaojiang Zheng China	15	626 1.0×	299 0.7×	211 0.9×	130 0.7×	119 0.7×	52	1.1k
Verena Köberle Germany	15	546 0.9×	443 1.0×	82 0.4×	194 1.0×	163 1.0×	19	898
Dianzhong Luo China	16	458 0.8×	250 0.6×	105 0.5×	101 0.5×	110 0.7×	27	946
Le Li China	17	559 0.9×	337 0.8×	301 1.3×	102 0.5×	43 0.3×	46	1.0k
Junko Kano Japan	19	527 0.9×	201 0.4×	163 0.7×	61 0.3×	112 0.7×	46	920
Xing Gu China	17	621 1.0×	203 0.5×	174 0.7×	159 0.9×	105 0.6×	60	1.0k
Meng Duan China	22	589 1.0×	307 0.7×	452 1.9×	165 0.9×	136 0.8×	42	1.4k

Countries citing papers authored by Thomas Pleli

Since Specialization

Citations

This map shows the geographic impact of Thomas Pleli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Pleli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Pleli more than expected).

Fields of papers citing papers by Thomas Pleli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Pleli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Pleli. The network helps show where Thomas Pleli may publish in the future.

Co-authorship network of co-authors of Thomas Pleli

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Pleli. A scholar is included among the top collaborators of Thomas Pleli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Pleli. Thomas Pleli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Waidmann, Oliver, Thomas Pleli, Andreas Weigert, et al.. (2020). Tax1BP1 limits hepatic inflammation and reduces experimental hepatocarcinogenesis. Scientific Reports. 10(1). 16264–16264. 10 indexed citations

Feczkó, Tivadar, Albrecht Piiper, Thomas Pleli, et al.. (2019). Theranostic Sorafenib-Loaded Polymeric Nanocarriers Manufactured by Enhanced Gadolinium Conjugation Techniques. Pharmaceutics. 11(10). 489–489. 20 indexed citations

Pleli, Thomas, Christian Schmithals, Stefan Zeuzem, et al.. (2018). Selective targeting of tumor associated macrophages in different tumor models. PLoS ONE. 13(2). e0193015–e0193015. 26 indexed citations

Pleli, Thomas, A. W. Mondorf, Nerea Ferreirós, et al.. (2018). Activation of Adenylyl Cyclase Causes Stimulation of Adenosine Receptors. Cellular Physiology and Biochemistry. 45(6). 2516–2528. 23 indexed citations

Ibrahim, Ahmed Atef, Christian Schmithals, Verena Köberle, et al.. (2017). Hypoxia Causes Downregulation of Dicer in Hepatocellular Carcinoma, Which Is Required for Upregulation of Hypoxia-Inducible Factor 1α and Epithelial–Mesenchymal Transition. Clinical Cancer Research. 23(14). 3896–3905. 31 indexed citations

Bachmann, Malte, Zoe Waibler, Thomas Pleli, Josef Pfeilschifter, & Heiko Mühl. (2017). Type I Interferon Supports Inducible Nitric Oxide Synthase in Murine Hepatoma Cells and Hepatocytes and during Experimental Acetaminophen-Induced Liver Damage. Frontiers in Immunology. 8. 890–890. 21 indexed citations

Finkelmeier, Fabian, Özge Canli, Andrea O. Tal, et al.. (2016). High levels of the soluble programmed death-ligand (sPD-L1) identify hepatocellular carcinoma patients with a poor prognosis. European Journal of Cancer. 59. 152–159. 171 indexed citations

Schmithals, Christian, Verena Köberle, Hüdayi Korkusuz, et al.. (2015). Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular Carcinoma. Cancer Research. 75(15). 3147–3154. 54 indexed citations

Köberle, Verena, Ahmed Atef Ibrahim, Christian Schmithals, et al.. (2015). Vesicle-associated microRNAs are released from blood cells on incubation of blood samples. Translational research. 169. 40–46. 15 indexed citations

10.

Scheiermann, Patrick, Malte Bachmann, Thomas Pleli, et al.. (2015). Application of IL-36 receptor antagonist weakens CCL20 expression and impairs recovery in the late phase of murine acetaminophen-induced liver injury. Scientific Reports. 5(1). 8521–8521. 28 indexed citations

11.

Pleli, Thomas, Daniel Martin, Bernd Kronenberger, et al.. (2014). Serum Autotaxin Is a Parameter for the Severity of Liver Cirrhosis and Overall Survival in Patients with Liver Cirrhosis – A Prospective Cohort Study. PLoS ONE. 9(7). e103532–e103532. 57 indexed citations

12.

Schmithals, Christian, Thomas Pleli, Verena Köberle, et al.. (2014). Detection of hepatocellular carcinoma in transgenic mice by Gd-DTPA- and rhodamine 123-conjugated human serum albumin nanoparticles in T1 magnetic resonance imaging. Journal of Controlled Release. 199. 63–71. 27 indexed citations

13.

Doller, Anke, Tobias Schmid, Thomas Pleli, et al.. (2014). The cytoskeletal inhibitors latrunculin A and blebbistatin exert antitumorigenic properties in human hepatocellular carcinoma cells by interfering with intracellular HuR trafficking. Experimental Cell Research. 330(1). 66–80. 31 indexed citations

14.

Schmithals, Christian, Thomas Pleli, Verena Köberle, et al.. (2013). Biodegradable human serum albumin nanoparticles as contrast agents for the detection of hepatocellular carcinoma by magnetic resonance imaging. European Journal of Pharmaceutics and Biopharmaceutics. 87(1). 132–141. 33 indexed citations

15.

Köberle, Verena, Bernd Kronenberger, Thomas Pleli, et al.. (2013). Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma. European Journal of Cancer. 49(16). 3442–3449. 154 indexed citations

16.

Köberle, Verena, Thomas Pleli, Christian Schmithals, et al.. (2013). Differential Stability of Cell-Free Circulating microRNAs: Implications for Their Utilization as Biomarkers. PLoS ONE. 8(9). e75184–e75184. 158 indexed citations

17.

Haupenthal, Jörg, Verena Bihrer, Hüdayi Korkusuz, et al.. (2012). Reduced Efficacy of the Plk1 Inhibitor BI 2536 on the Progression of Hepatocellular Carcinoma due to Low Intratumoral Drug Levels. Neoplasia. 14(5). 410–IN10. 44 indexed citations

18.

Waidmann, Oliver, Verena Bihrer, Thomas Pleli, et al.. (2012). 490 SERUM MICRORNA-122 LEVELS IN DIFFERENT GROUPS OF PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION. Journal of Hepatology. 56. S193–S193. 7 indexed citations

19.

Waidmann, Oliver, Verena Bihrer, Thomas Pleli, et al.. (2011). Serum microRNA‐122 levels in different groups of patients with chronic hepatitis B virus infection. Journal of Viral Hepatitis. 19(2). e58–65. 109 indexed citations

20.

Waidmann, Oliver, Thomas Pleli, Karel Dvořák, et al.. (2009). Inhibition of the Equilibrative Nucleoside Transporter 1 and Activation of A2A Adenosine Receptors by 8-(4-Chlorophenylthio)-modified cAMP Analogs and Their Hydrolytic Products. Journal of Biological Chemistry. 284(47). 32256–32263. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tianqiang Song Breakdown of academic impact, for papers by Shaojiang Zheng Breakdown of academic impact, for papers by Verena Köberle Breakdown of academic impact, for papers by Dianzhong Luo Breakdown of academic impact, for papers by Le Li Breakdown of academic impact, for papers by Junko Kano Breakdown of academic impact, for papers by Xing Gu Breakdown of academic impact, for papers by Meng Duan